publication venue for
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.. 379:1388-1389. 2018
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. 378:e34-e34. 2018
- Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.. 378:2441-2442. 2018
- Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.. 379:2429-2437. 2018
- Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia. 378:148-157. 2018
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. 377:1345-1356. 2017
- A Randomized, Controlled Trial of Total Knee Replacement. 374:691-692. 2016
- Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia. 373:1497-1506. 2015
- A Randomized, Controlled Trial of Total Knee Replacement. 373:1597-1606. 2015
- Intensive Lifestyle Intervention in Type 2 Diabetes. 369:2356-2356. 2013
- Intensive Lifestyle Intervention in Type 2 Diabetes. 369:2356-2356. 2013
- Intensive Lifestyle Intervention in Type 2 Diabetes. 369:2356-2357. 2013
- Intensive Lifestyle Intervention in Type 2 Diabetes. 369:2357-2358. 2013
- Intensive Lifestyle Intervention in Type 2 Diabetes REPLY. 369:2358-2359. 2013
- Mediterranean Diet for Primary Prevention of Cardiovascular Disease. 369:672-673. 2013
- Mediterranean Diet for Primary Prevention of Cardiovascular Disease. 369:674-674. 2013
- Mediterranean Diet for Primary Prevention of Cardiovascular Disease. 369:673-674. 2013
- Mediterranean Diet for Primary Prevention of Cardiovascular Disease. 369:674-675. 2013
- Mediterranean Diet for Primary Prevention of Cardiovascular Disease. 369:675-676. 2013
- Primary prevention of cardiovascular disease with a Mediterranean diet. 368:1279-1290. 2013
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction. 367:1310-1320. 2012
- Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. 367:1694-1703. 2012
- Long-Term Persistence of Hormonal Adaptations to Weight Loss. 365:1597-1604. 2011
- The authors reply. 363:1872-1873. 2010
- A Randomized Trial of Treatment for Acute Anterior Cruciate Ligament Tears. 363:331-342. 2010
- K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer. 359:1757-1765. 2008
- Reducing Injuries from Falls. 359:1626-1626. 2008
- Cetuximab for the Treatment of Colorectal Cancer. 357:2040-2048. 2007
- Whole-Genome Analysis of Sporadic Amyotrophic Lateral Sclerosis. 357:775-788. 2007
- Dyspnea and Risk in Suspected Coronary Disease. 353:1963-1965. 2005
- The Prognostic Value of a Nomogram for Exercise Capacity in Women. 353:468-475. 2005
- The chromogranin-secretogranin family [4] (multiple letters). 348:2579-2580. 2003
- The Chromogranin–Secretogranin Family. 348:1134-1149. 2003
- Fortification of Foods with Folic Acid. 343:970-972. 2000
- Metabolic Staging of Lung Cancer. 343:290-292. 2000
- Informed Consent and Approval by Institutional Review Boards in Published Reports on Clinical Trials. 340:1114-1115. 1999
- Clinical Features Associated with Mutations in the Chromosome 1 Open-Angle Glaucoma Gene ( GLC1A ). 338:1022-1027. 1998
- Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. 336:1689-1696. 1997
- Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms. 314:1145-1151. 1986
- Radioimmunoassay of Chromogranin a in Plasma as a Measure of Exocytotic Sympathoadrenal Activity in Normal Subjects and Patients with Pheochromocytoma. 311:764-770. 1984
- Renal Blood Flow during Nadolol Administration. 308:49-50. 1983
- Labor Induction vs. Expectant Management of Low-Risk Pregnancy 2018
- The authors reply 2016
- Mediterranean Diet for Primary Prevention of Cardiovascular Disease 2013
- Intensive lifestyle intervention in type 2 diabetes 2013